Table 5.
Parameters | Univarite analysis | Multivarite analysis | ||||
---|---|---|---|---|---|---|
Odd ratio | 95% CI | p value | Odd ratio | 95% CI | p value | |
Age at operation (years old) ≤ 60 vs > 60 | 1.636 | 0.873–3.065 | 0.124 | |||
Tumor size (mm) ≤ 10.0 vs > 10.0 | 3.534 | 1.056–11.825 | 0.017 | 2.639 | 0.888–11.346 | 0.085 |
Estrogen receptor Negative vs Positive | 1.249 | 0.528–2.955 | 0.606 | |||
Progesterone receptor Negative vs Positive | 1.246 | 0.648–2.395 | 0.506 | |||
Hormone receptor Negative vs Positive | 1.159 | 0.488–2.748 | 0.735 | |||
HER2 Negative vs Positive | 1.205 | 0.392–3.700 | 0.749 | |||
Ki67 ≤ 14% vs > 14% | 0.827 | 0.430–1.590 | 0.567 | |||
Lymphatic invasion ly0 vs ly1 | 2.792 | 1.476–5.282 | 0.002 | 2.522 | 1.280–4.973 | 0.008 |
Venous invasion v0 vs v1 | 2.794 | 0.823–9.481 | 0.124 | |||
Nuclear grade 1, 2 vs 3 | 1.215 | 0.475–3.105 | 0.689 | |||
TILs 0, 1 vs 2, 3 | 0.495 | 0.187–1.311 | 0.128 | |||
TILs 0 vs 1–3 | 0.117 | 0.049–0.277 | < 0.001 | 0.137 | 0.055–0.335 | < 0.001 |
CI confidence intervals, HER2 human epidermal growth factor receptor 2, TILs tumor- infiltrating lymphocytes